 Nanotherapeutics is rapidly advancing as a solution to the limitations of conventional drug delivery systems in cancer chemotherapy, including lack of selectivity, multi-drug resistance, and poor aqueous solubility, through targeted delivery, reversal of multi-drug resistance, and improved bioavailability. This article was authored by Murdi Chidambaram, Arman Balan and K. Kuthiresan.